A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Chordoma
Clinical trial NCT06787664 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06787664
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-16
- Primary completion
- 2027-06-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.